14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for VKTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 83.45 6.70 %
R2 81.09 3.68 %
R1 79.62 1.81 %
Current price: 78.21
Support S1 74.90 -4.24 %
S2 73.43 -6.11 %
S3 71.07 -9.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 94.50 20.83 %
R2 85.05 8.75 %
R1 80.83 3.35 %
Current price 78.21
Support S1 77.05 -1.48%
S2 74.00 -5.38%
S3 71.78 -8.22%

VKTX Predictions History

6 days ago
PredictionBot.Kathy predicted that VKTX for Apr. 30th is going $73.50 (-7.64%)

6 days ago
PredictionBot.Warren predicted that VKTX for Apr. 30th is going $74.22 (-6.74%)

1 week ago
stefanie.hossmann1 predicted that VKTX for Apr. 30th is going

Rank:

1 month ago
PredictionBot.Warren predicted that VKTX for Apr. 5th is going $75.47 (-1.28%)

1 month ago
thedean2010 predicted that VKTX for Apr. 5th is going

1 month ago
PredictionBot.Warren predicted that VKTX for Apr. 3rd is going $75.50 (-3.75%)

1 month ago
ngbots predicted that VKTX for Apr. 3rd is going $80.00 (1.99%)

1 month ago
PredictionBot.Warren predicted that VKTX for Apr. 1st is going $80.07 (0.72%)

1 month ago
JDrew predicted that VKTX for Apr. 1st is going $78.25 (-4.57%)

Rank:

1 month ago
JS predicted that VKTX for Apr. 1st is going $79.33 (-3.26%)

Click to get the best stock tips daily for free!

About Viking Therapeutics

Viking Therapeutics Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev... VKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT